Tool effective for rapid cataract screening

Article

Catatrac may be a low-cost and effective tool for the rapid screening of visually significant cataracts in the developing world, claims a paper in the journal Eye.

Catatrac may be a low-cost and effective tool for the rapid screening of visually significant cataracts in the developing world, claims a paper in the journal Eye.

A team led by Dr M.Q. Rahman, Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK, divided 122 eyes of 73 patients into two groups- mild cataracts with logMAR acuities of less than 0.48 and advanced cataracts with logMAR acuities greater than or equal to 0.48.

All patients were assessed without pharmacological dilation in a dimly lit room. A slit lamp was used to examine each patient and the LOCS III classification system was used to grade cataracts.

Of the patients studied, 39 had mild cataracts, 43 eyes had advanced cataracts and there were 40 control eyes with no cataracts. The Catatrac device had a specificity of 95%, a sensitivity of 71 to 84.6% and κ values between 0.67 and 0.80 for agreement with slit lamp assessment.

Overall, the Catatrac device has a slightly lower sensitivity for mild cataracts the authors state it may be an efficient and cheap tool for screening visually significant cataracts in the developing world.

To read the abstract visit the website.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.